SBC Medical Group Holdings Incorporated
SBC
$3.22
-$0.06-1.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Revenue | 12.28% | 29.51% | 27.72% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 12.28% | 29.51% | 27.72% | ||
| Cost of Revenue | -28.55% | 50.71% | 6.19% | ||
| Gross Profit | 29.08% | 23.48% | 38.59% | ||
| SG&A Expenses | 121.05% | -26.02% | -13.27% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -37.20% | -6.80% | -47.89% | ||
| Total Operating Expenses | 44.01% | 1.50% | -4.67% | ||
| Operating Income | -30.91% | 75.27% | 120.82% | ||
| Income Before Tax | -37.79% | 62.49% | 121.61% | ||
| Income Tax Expenses | -21.05% | 25.16% | 44.31% | ||
| Earnings from Continuing Operations | -64.82% | 88.30% | 192.15% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -100.54% | -108.96% | 101.81% | ||
| Net Income | -66.10% | 73.25% | 212.50% | ||
| EBIT | -30.91% | 75.27% | 120.82% | ||
| EBITDA | -36.28% | 46.67% | 83.64% | ||
| EPS Basic | -66.40% | 73.25% | -- | ||
| Normalized Basic EPS | -36.85% | 50.07% | -- | ||
| EPS Diluted | -66.40% | 73.25% | -- | ||
| Normalized Diluted EPS | -36.85% | 50.07% | -- | ||
| Average Basic Shares Outstanding | 0.96% | 0.00% | -- | ||
| Average Diluted Shares Outstanding | 0.96% | 0.00% | -- | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||
